Growth Metrics

Surgery Partners (SGRY) Long-Term Investments (2016 - 2025)

Surgery Partners (SGRY) has disclosed Long-Term Investments for 12 consecutive years, with $234.0 million as the latest value for Q4 2025.

  • Quarterly Long-Term Investments rose 8.64% to $234.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $234.0 million through Dec 2025, up 8.64% year-over-year, with the annual reading at $234.0 million for FY2025, 8.64% up from the prior year.
  • Long-Term Investments hit $234.0 million in Q4 2025 for Surgery Partners, up from $229.4 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $234.0 million in Q4 2025 to a low of $88.7 million in Q4 2021.
  • Historically, Long-Term Investments has averaged $175.2 million across 5 years, with a median of $191.0 million in 2022.
  • Biggest five-year swings in Long-Term Investments: soared 114.54% in 2022 and later decreased 3.26% in 2023.
  • Year by year, Long-Term Investments stood at $88.7 million in 2021, then skyrocketed by 114.54% to $190.3 million in 2022, then decreased by 3.26% to $184.1 million in 2023, then rose by 17.0% to $215.4 million in 2024, then grew by 8.64% to $234.0 million in 2025.
  • Business Quant data shows Long-Term Investments for SGRY at $234.0 million in Q4 2025, $229.4 million in Q3 2025, and $220.2 million in Q2 2025.